TradeHorde's multi-model system has generated 1 signal on SPDR S&P Biotech ETF (XBI), with transparent outcome tracking on every resolved setup.
Latest forecast: Bullish at 57% conviction based on consensus across 3 frontier models.
1 signal resolved on XBI. See full analysis and outcomes.